19 Jun 2026
Alembic Pharmaceuticals won USFDA tentative approval for its binimetinib tablet, a drug with US sales of about 260 million dollars.
Tentative approval confirms the filing's quality while final clearance waits on the innovator's patent and exclusivity expiry.

Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630. Stock notes are market commentary for general information and education. They are not investment advice, not a recommendation to buy or sell, and do not account for any individual's financial situation. Investment in securities is subject to market risks. Please read all related documents carefully before investing. Past performance is not a guarantee of future results.